These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 22882457

  • 1. Adjuvant selection for vaccination against murine schistosomiasis.
    El Ridi R, Tallima H.
    Scand J Immunol; 2012 Dec; 76(6):552-8. PubMed ID: 22882457
    [Abstract] [Full Text] [Related]

  • 2. Innate immunogenicity and in vitro protective potential of Schistosoma mansoni lung schistosomula excretory--secretory candidate vaccine antigens.
    El Ridi R, Tallima H, Mahana N, Dalton JP.
    Microbes Infect; 2010 Sep; 12(10):700-9. PubMed ID: 20452455
    [Abstract] [Full Text] [Related]

  • 3. Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines.
    El Ridi R, Tallima H.
    J Parasitol; 2013 Apr; 99(2):194-202. PubMed ID: 22985345
    [Abstract] [Full Text] [Related]

  • 4. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R, Tallima H.
    Vaccine; 2009 Jan 29; 27(5):666-73. PubMed ID: 19056448
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni.
    Pearce EJ, Caspar P, Grzych JM, Lewis FA, Sher A.
    J Exp Med; 1991 Jan 01; 173(1):159-66. PubMed ID: 1824635
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice.
    Tallima H, Tadros MM, El Ridi R.
    Acta Trop; 2024 Jun 01; 254():107208. PubMed ID: 38621620
    [Abstract] [Full Text] [Related]

  • 10. Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.
    Ahmad G, Zhang W, Torben W, Noor Z, Siddiqui AA.
    Int J Infect Dis; 2010 Sep 01; 14(9):e781-7. PubMed ID: 20630783
    [Abstract] [Full Text] [Related]

  • 11. Th1 cytokine mRNA expression dominates in the skin-draining lymph nodes of C57BL/6 mice following vaccination with irradiated Schistosoma mansoni cercariae, but is down-regulated upon challenge infection.
    Betts CJ, Wilson RA.
    Immunology; 1998 Jan 01; 93(1):49-54. PubMed ID: 9536118
    [Abstract] [Full Text] [Related]

  • 12. Impact of interleukin-1 and interleukin-6 in murine primary schistosomiasis.
    El Ridi R, Wagih A, Salem R, Mahana N, El Demellawy M, Tallima H.
    Int Immunopharmacol; 2006 Jul 01; 6(7):1100-8. PubMed ID: 16714213
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor-beta and Th17 responses in resistance to primary murine schistosomiasis mansoni.
    Tallima H, Salah M, Guirguis FR, El Ridi R.
    Cytokine; 2009 Dec 01; 48(3):239-45. PubMed ID: 19717308
    [Abstract] [Full Text] [Related]

  • 14. SjHSP70, a recombinant Schistosoma japonicum heat shock protein 70, is immunostimulatory and induces protective immunity against cercarial challenge in mice.
    Duan MM, Xu RM, Yuan CX, Li YY, Liu Q, Cheng GF, Lin JJ, Feng XG.
    Parasitol Res; 2015 Sep 01; 114(9):3415-29. PubMed ID: 26091761
    [Abstract] [Full Text] [Related]

  • 15. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection.
    Da'Dara AA, Skelly PJ, Walker CM, Harn DA.
    Parasite Immunol; 2003 Sep 01; 25(8-9):429-37. PubMed ID: 14651590
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection.
    Martins VP, Morais SB, Pinheiro CS, Assis NR, Figueiredo BC, Ricci ND, Alves-Silva J, Caliari MV, Oliveira SC.
    PLoS Negl Trop Dis; 2014 Mar 01; 8(3):e2750. PubMed ID: 24651069
    [Abstract] [Full Text] [Related]

  • 20. Antigens derived from lung-stage larvae of Schistosoma mansoni are efficient stimulators of proliferation and gamma interferon secretion by lymphocytes from mice vaccinated with attenuated larvae.
    Mountford AP, Harrop R, Wilson RA.
    Infect Immun; 1995 May 01; 63(5):1980-6. PubMed ID: 7729911
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.